Mr. Menendez (for himself and Ms. Collins) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions
To direct the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health, to take certain steps to increase clinical trial diversity, and for other purposes.
Citations are generated automatically from bibliographic data as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. Senate. NIH Clinical Trial Diversity Act of 2023. S. 1701. 118th
Cong., 1st
sess., Introduced in Senate May 18, 2023. https://www.govinfo.gov/app/details/BILLS-118s1701is.
APA
Congress, Senate (2023, May 18). NIH Clinical Trial Diversity Act of 2023 (S. 1701 (IS)). Retrieved from https://www.govinfo.gov/app/details/BILLS-118s1701is.
MLA
United States, Congress, Senate. NIH Clinical Trial Diversity Act of 2023. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-118s1701is. 118th Congress, S. 1701, Introduced in Senate 18 May. 2023.
Bluebook
S.1701 - 118th Congress (2023-2024): NIH Clinical Trial Diversity Act of 2023, S.1701, 118th Cong. (2023), https://www.govinfo.gov/app/details/BILLS-118s1701is.
